. Author manuscript; available in PMC: 2023 Feb 1.

Published in final edited form as: Int J Drug Policy. 2021 Nov 7;100:103518. doi: 10.1016/j.drugpo.2021.103518

Table 3.

Bivariate and multivariable generalized linear mixed modeling (GLMM) analyses for the association between classic psychedelic use and daily illicit opioid use among people who use drugs in Vancouver, Canada (2006–2018).

Classic psychedelic use^†	Unadjusted Odds Ratio (95%CI)	p-value	Adjusted Odds Ratio (95%CI)	p-value
	0.59 (0.40 to 0.87)	0.007	0.45 (0.29 to 0.70) ^*	<0.001

^†

Responses lagged to prior visit.

Adjusted for age, HIV, childhood trauma, homelessness, daily cannabis use, daily stimulant use, and enrolled in opioid and other drug treatment; time-updated to refer to the last six months.